ReviewJournal of the American Heart Association2020

Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy.

Jonathan P Law et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.